Allianz Reports Safety Gains From Automated Mobility and Urges EU-Wide “Driving License” for Autonomous Vehicles
The promise of autonomous mobility is not just a technological leap – it represents a transformation in safety, comfort, and accessibility that is already underway with Level 3 vehicles on European roads and Level 4 systems operating in real-world test fields. At the 13th Allianz Motor Day in 2025, hosted by the Allianz Center for Technology (AZT), Allianz unveiled significant safety gains from autonomous vehicles and calls for EU-wide testing standards to ensure their safe integration into European roads, including questions about vehicle safety, liability, the use of in-vehicle data from autonomous vehicles (AVs), and more inclusive mobility. The company already insures test fields in several countries, including Germany, Norway, and Singapore.
AZT research and proprietary claims analysis indicate a significant decline in motor liability claims frequency driven by advanced driver assistance systems (ADAS) now available in select models. While these systems already demonstrate impressive potential, consumers across Europe still view automated driving technology as relatively untested, although they expect strong safety and comfort gains. These findings, published in the Allianz report “HANDS OFF – The Safety Promise of Autonomous Mobility”, highlight the transformative effect of automated systems on road safety and insurance dynamics.
“Autonomous mobility is no longer a question of if. It’s about how fast, how safe and how fair. Every technological advancement must translate into fewer collisions, fewer victims, and greater independence for millions. At Allianz, we see autonomous driving as a shared responsibility to build safer and more inclusive mobility. Together with the Allianz Center for Technology, manufacturers, and regulators, we will shape safety standards and pilot innovative insurance solutions. The future of mobility will be autonomous, but safety must always remain in human hands,” said Dr.Klaus-Peter Röhler,Member of the Board of Management of Allianz SE, Insurance German Speaking Countries, Central Europe, Global Property & Casualty. His keynote at the Allianz Motor Day 2025 is available here.
As a safety-focused leader in mobility innovation, Allianz advocates for a European “driving license” for autonomous systems. For AVs to be able to use European roads in the future, they will need to be approved. From Allianz’s perspective, the certification process is not yet comprehensively regulated under EU 2022/1426. Therefore, the insurer proposes a combination of digital driving simulations, a practical test under identical defined conditions (e.g., braking or evasive maneuvers) and a real-world test in various driving conditions (e.g., night or motorway). To clarify accidents and learn from near misses, Allianz advocates for a Europe-wide database operated jointly by manufacturers, regulators, and insurers.
“We are calling for an EU-wide uniform testing approach for autonomous vehicles to ensure reliable verification of the necessary safety standards across the EU. Let’s call it a ’driving license’ for autonomous vehicles. Just as humans must prove they can drive safely, autonomous vehicles must prove that they can steer and navigate safely in all driving situations. Open access to accident- and safety-related vehicle data is essential to ensure accountability and maintain public confidence,” said Röhler.
Safety Gains and Predictions
The AZT has examined the safety performance of autonomous driving and predicts that automation will sharply reduce accidents caused by human error, such as fatigue, distraction, or misjudgment. The AZT forecasts a 20 percent drop in road-traffic accidents in Europe by 2035, rising to more than 50 percent from 2060 onwards, using 2023 as the base year, as the mix of conventional (Levels 1 and 2) and automated (Levels 3 and 4) vehicles scales up. This outlook incorporates the future market penetration of active operating systems under conservative to progressive scenarios and the impact of mixed traffic with vehicles without autonomous systems– rather than solely the technical potential. It is based on in-house modeling as well as a data from the German insurance association GDV.
Already in today’s cars, ADAS with automated emergency braking (AEB) underscore this high safety potential. Based on an analysis of 20,000 Allianz motor insurance liability claims, rear-end collisions in flowing traffic fell by 30 percent on average when AEB was installed as standard. The most advanced systems reduced reversing crashes in parking scenarios by 66 percent.
“The message is consistent: when effective advanced driver assistance systems are deployed as standard equipment, safety gains are immediate and significant. Where adoption is partial or left to optional packages, benefits stay modest. For Allianz, this highlights the importance of broad, standardized implementation of driver assistance systems as a legal requirement,” said Dr. Christian Sahr, Head of Allianz Center for Technology (AZT).
Fewer accidents will mean fewer claims; yet the value of each claim will rise as AVs become more technologically complex. Lower claim frequency is offset by higher repair bills, mainly due to the cost of sensors and rising prices for parts and labor. Physical damage claims from hail or theft will prevail, while new forms of risk – from software failures to cyberattacks – will demand new kinds of cover.
“Autonomous vehicles will also transform how we assess and price risk. While traditional vehicle classification – based on historical claims frequency – remains relevant, their importance will gradually decline as we emphasize driver assistance system safety performance. We are evolving our pricing models by complementing existing type classifications with a safety scoring model that reflects how both the vehicle and its systems contribute to the overall risk. This will ensure a more accurate and forward-looking approach to premium setting. At a time when consumers face rising living costs, autonomy can deliver both safety and affordability of motor insurance,” said Röhler.
Consumer Survey Insights: Confidence and Caution
To gauge trust and acceptance of AVs, Allianz conducted a representative consumer survey in seven European countries (Austria, Germany, France, Italy, Switzerland, the Czech Republic, and the United Kingdom). The results demonstrate broad confidence in safety improvements but also highlight uncertainty regarding technological maturity.
More than half of respondents (56 percent) expect autonomous cars to be safer or at least as safe as human-driven vehicles. Consumers also value potential comfort gains, such as using travel time for other activities (50 percent of respondents), as well as greater mobility for themselves (40 percent) and for people with disabilities and older adults (65 percent).
At the same time, concerns remain: 69 percent worry about system reliability in unexpected situations, and 72 percent view the technology as still “too new and untested.” 64 percent would feel comfortable in AVs only if they could take back control at any time. A European comparison shows that Italians have the highest level of confidence in the safety of autonomous vehicles (65 percent). Respondents in the United Kingdom are most critical (44 percent). Germans fall in the middle at 57 percent).
“What’s clear is that across Europe trust hinges less on perfection and more on proof. People not only want autonomous vehicles to match or exceed human safety, they want this backed by transparent data, strict oversight and clear accountability,” said Röhler.
Liability and Insurance Considerations
When responsibility for steering shifts from humans to machines, determining liability after an accident becomes more complex. The question is whether autonomous driving requires a new liability system or whether traditional motor insurance will eventually be replaced by product liability for the manufacturer or operator. In mixed traffic, where autonomous and human-driven vehicles coexist, liability may involve multiple parties, including vehicle owners, manufacturers, software developers and remote supervisors.
“Allianz’s position is clear: Victim protection must remain central to autonomous vehicle insurance. Liability must stay with the vehicle owner, no matter whether a human driver or a machine is in control. And motor insurers must remain the first point of contact for victims. We are committed to supporting victims through continued strict liability insurance, ensuring that they are not left to navigate complex liability disputes on their own and that they receive compensation for their damages quickly and easily from their insurer,” emphasized Röhler.
Three Allianz Priorities for Safe Autonomous Mobility
Allianz sets out three priorities to accelerate the safe adoption of autonomous mobility while safeguarding consumers and strengthening Europe's leadership in mobility innovation:
- EU-wide ‘driving license’ for automated vehicles to ensure uniform testing standards: Allianz calls for a European approval model for autonomous vehicles with uniform technical type approval (homologation) and testing procedures. These should specify the requirements that autonomous vehicles must meet and regulate the simulations and tests they must pass. This would enable cross-border use without repeated certification, simplify market access, increase safety, and accelerate innovation.
- EU-wide uniform standards for access to accident- and safety-related vehicle data for insurers and regulatory authorities, with critical data remaining within European jurisdiction and treated as a strategic asset.
The European Commission's proposal on the exchange of vehicle data under the EU Data Act (Regulation 2023/2854) provides an important basis for this. Allianz believes that use cases for data exchange should be evaluated for both benefits and costs. Sharing all available data across the board is not sensible given the considerable expense. Consumers should also be protected from indiscriminately passing on all their car data to third parties. For accident- and safety-related vehicle data, however, the advantages are clear. A framework developed jointly by insurers, manufacturers, and regulatory authorities would improve road safety, strengthen public confidence, and accelerate the acceptance of autonomous mobility. - Joint European database of critical traffic situations for autonomous vehicles. This database must record all accidents in autonomous mode and near misses where accidents were narrowly avoided. The regulatory authorities must define the criteria for this.
Downloads | Further links |
Allianz Motor Day 2025 on allianz.com Report “HANDS OFF – the safety promise of autonomous mobility” | |
About Allianz
The Allianz Group is one of the world's leading insurers and asset managers serving private and corporate customers in nearly 70 countries. Allianz customers benefit from a broad range of personal and corporate insurance services, ranging from property, life and health insurance to assistance services to credit insurance and global business insurance. Allianz is one of the world’s largest investors, managing around 749 billion euros* on behalf of its insurance customers. Furthermore, our asset managers PIMCO and Allianz Global Investors manage about 1.8 trillion euros* of third-party assets. Thanks to our systematic integration of ecological and social criteria in our business processes and investment decisions, we are among the leaders in the insurance industry in the Dow Jones Sustainability Index. In 2024, over 156,000 employees achieved total business volume of 179.8 billion euros and an operating profit of 16.0 billion euros for the Group.
* As of June 30, 2025.
Mandatory corporate information: Corporate disclosures
These assessments are, as always, subject to the disclaimer provided below.
Cautionary note regarding forward-looking statements
This document includes forward-looking statements, such as prospects or expectations, that are based on management's current views and assumptions and subject to known and unknown risks and uncertainties. Actual results, performance figures, or events may differ significantly from those expressed or implied in such forward-looking statements.
Deviations may arise due to changes in factors including, but not limited to, the following: (i) the general economic and competitive situation in the Allianz’s core business and core markets, (ii) the performance of financial markets (in particular market volatility, liquidity, and credit events), (iii) adverse publicity, regulatory actions or litigation with respect to the Allianz Group, other well-known companies and the financial services industry generally, (iv) the frequency and severity of insured loss events, including those resulting from natural catastrophes, and the development of loss expenses, (v) mortality and morbidity levels and trends, (vi) persistency levels, (vii) the extent of credit defaults, (viii) interest rate levels, (ix) currency exchange rates, most notably the EUR/USD exchange rate, (x) changes in laws and regulations, including tax regulations, (xi) the impact of acquisitions including related integration issues and reorganization measures, and (xii) the general competitive conditions that, in each individual case, apply at a local, regional, national, and/or global level. Many of these changes can be exacerbated by terrorist activities.
No duty to update
Allianz assumes no obligation to update any information or forward-looking statement contained herein, save for any information we are required to disclose by law.
Privacy Note
Allianz SE is committed to protecting your personal data. Find out more in our privacy statement.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251027184218/en/
Contacts
For further information, please contact:
Christina Bersick
Tel. +49 89 3800 12949
E-Mail: christina.bersick@allianz.de
Heidi Polke
Tel. +49 89 3800 99777
E-Mail: heidi.polke@allianz.com
Patricia Segovia
Tel. +49 89 3800 67589
E-Mail: patricia.segovia@allianz.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Compass Pathways to Announce Third Quarter Financial Results on November 4, 202528.10.2025 12:30:00 EET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the third quarter ended September 30, 2025, and provide an update on recent developments, on November 4, 2025. Compass management will host a conference call at 8:00 am ET (1:00 pm UK) on November 4, 2025. A live webcast of the call will be available on the Compass Pathways website at: https://events.q4inc.com/attendee/698442687. The webcast will be archived for 30 days. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid
BeOne Medicines to Present at Upcoming Investor Conferences28.10.2025 12:01:00 EET | Press release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in fireside chats at two upcoming investor conferences: Guggenheim Second Annual Healthcare Innovation Conference on Monday, November 10, 2025 at 9:30 am EST; and Jefferies Global Healthcare Conference in London on Monday, November 17, 2025 at 4:00 pm GMT/11:00 am EST Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through
Ares Management and Slate Asset Management to Acquire Polish Real Estate Portfolio Valued at Over €300 Million From Trei Real Estate28.10.2025 10:15:00 EET | Press release
Ares Management Corporation (“Ares”) (NYSE: ARES), a leading global alternative investment manager, and Slate Asset Management (“Slate”), a global investor and manager focused on essential real estate and infrastructure, today announced that a joint venture between Ares Real Estate funds (“Ares Real Estate”) and Slate has agreed to acquire a portfolio of 36 properties in Poland (the “Portfolio”) from Trei Real Estate, an internationally active developer and asset manager. The Portfolio is valued at over €300 million. The Portfolio comprises 36 recently developed and fully occupied convenience-led retail parks strategically located across major Polish metropolitan areas near large catchment populations. The assets are inflation-protected through CPI-linked lease agreements underpinned by tenants with strong covenants. Most of the Portfolio’s income is derived from large regional retailers and essential goods providers, including grocers and pharmacies. “This transaction underlines our c
SK pharmteco Achieves Highest-Level My Green Lab Certifications Across Europe and Asia28.10.2025 10:00:00 EET | Press release
SK pharmteco, a global contract development and manufacturing organization (CDMO), today announced a significant milestone in its commitment to environmental sustainability by earning four My Green Lab certifications, including two at the program’s highest level, Green. The remaining two labs earned Gold certification, reflecting advanced sustainability performance and progression toward full Green maturity. The certified facilities are Small Molecule Europe (Swords, Ireland) and Small Molecule Asia (Daejeon, South Korea), and the certifications cover the areas of Quality Control, Process Research & Development, and Analytical Research & Development. My Green Lab certification is widely regarded as the global standard for laboratory sustainability, recognized by the United Nations Race to Zero campaign for its rigor in advancing credible decarbonization. Green certification is the program’s highest designation, reserved for laboratories that demonstrate exceptional, independently verif
Kemwell Biopharma Facility in Bengaluru Successfully Completes U.S. FDA Inspection for Commercial Drug-Product Manufacturing28.10.2025 08:00:00 EET | Press release
Kemwell Biopharma Pvt Ltd (“Kemwell”), a leading global biologics Contract Development and Manufacturing Organization (CDMO), announced today that its drug-product manufacturing facility in Bengaluru has successfully completed a U.S. Food and Drug Administration (FDA) pre-approval inspection (PAI) and is now cleared for the commercial manufacturing and testing of injectable products destined for the U.S. market. This milestone marks the approval of the first product to get U.S. FDA clearance for commercial supply from Kemwell’s Bengaluru drug-product facility since the site became a dedicated biologics campus eight years ago. It demonstrates the company’s ability to meet stringent current Good Manufacturing Practice (cGMP) and aseptic drug-product manufacturing standards. “Achieving FDA clearance for commercial manufacturing from our Bengaluru site marks a defining moment in Kemwell’s growth journey,” said Anurag Bagaria, Chairman and CEO, Kemwell Biopharma. “It reflects our team’s ste
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom